Oral Nuzolvence Approved for Uncomplicated Gonorrhea

Originally published by our sister publication Infectious Disease Special EditionBy IDSE News StaffThe FDA approved a second oral medication, zoliflodacin (Nuzolvence, Innoviva Specialty Therapeutics)—granules that dissolve in water—to treat uncomplicated urogenital gonorrhea in adults and children 12 years of age and older who weigh at least 77 pounds.In a pivotal phase 3, multinational, randomized controlled, open-label, noninferiority trial, zoliflodacin demonstrated noninferiorit